藥明康德(02359.HK):股東上海瀛翊違反承諾減持 減持總金額28.94億元
格隆匯6月11日丨藥明康德(02359.HK)公佈,公司於2021年6月11日收到公司股東上海瀛翊投資中心(有限合夥)("上海瀛翊")《關於違反承諾減持股份的情況説明及致歉函》。
2021年5月14日至6月7日,上海瀛翊通過上海證券交易所集中競價交易系統減持公司1610.80萬股(2020年度權益分派前)A股股份,2021年6月8日上海瀛翊通過上海證券交易所集中競價交易系統減持公司114.17萬股(2020年度權益分派後)A股股份,該等股份合計1724.97萬股,約佔公司總股本的0.6962%,減持價格區間為143.49元/股至176.88元/股,減持總金額為28.94億元。截至公吿日,上海瀛翊持有公司417.46萬股A股股份,約佔公司總股本的0.1419%。
上海瀛翊在實施此次減持之前未能遵守其作為委託投票方作出的有關減持公司股份的相關承諾,未提前通知公司,也沒有提前15個交易日通過公司披露減持計劃履行公吿等相關程序。
上海瀛翊就上述違反承諾給出的主要原因為:上海瀛翊減持前持股佔公司總股本的0.8381%,未達總股本的1%,相關工作人員未能意識到作為委託投票方,上海瀛翊在公司A股上市時已經作出有關減持公司股份的承諾,應適用中國證券監督管理委員會("中國證監會")《上市公司股東、董監高減持股份的若干規定》以及《上海證券交易所上市公司股東及董監高減持股份實施細則》等相關規定,導致了此次違反承諾減持行為。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.